Stories about Metabolism

Subscribe to topic

Subscribe to Metabolism

09.01.2020 – 09:03
Technische Universität München
Gene network helps to turn white fat into beneficial calorie burning fat
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/ High resolution images: https://mediatum.ub.tum.de/1524726 NEWS RELEASE A new approach to treating overweight and obesity Gene network helps to turn white fat into beneficial calorie ...
more
16.12.2019 – 17:07
Technische Universität München
From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35822/ High resolution images: https://mediatum.ub.tum.de/1524870 NEWS RELEASE From cancer medication ...
more
04.12.2019 – 12:22
APR Applied Pharma Research s.a.
FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa
Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa ("APR"), the Swiss pharma company focused in niche and rare therapeutic areas, announces that the US Food and Drug Administration (the "FDA") has granted Orphan Drug Designation for its investigational drug code-named APR-TD011 for treatment of ...
more
25.10.2019 – 10:03
Helmholtz Zentrum München
Helmholtz Zentrum München allies with Eli Lilly and Company to discover new targets for pancreatic beta cell regeneration in the treatment of diabetes
more
21.10.2019 – 17:03
Helmholtz Zentrum München
Identification of a ferroptosis suppressor protein allows for new anticancer treatment approach
more
14.10.2019 – 17:27
Helmholtz Zentrum München
Discovery of potential novel therapeutic target for non-alcoholic fatty liver disease
more
04.10.2019 – 11:05
Technische Universität München
Weak spot in pathogenic bacteria: ClpX-ClpP protein complex could be starting point for new antibiotics
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35720/ High resolution images: https://mediatum.ub.tum.de/1520810 NEWS RELEASE Weak spot in pathogenic bacteria ClpX-ClpP protein complex could be starting ...
more
17.09.2019 – 15:45
Novo Nordisk A/S
Ozempic® Offers Superior Reductions in HbA1c and Body Weight Compared to Both Victoza® and Canagliflozin in People With Type 2 Diabetes
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk announced today the results from two Ozempic® (once-weekly semaglutide 1.0 mg) head-to-head Phase 3 clinical trials, SUSTAIN 8 and SUSTAIN 10, which showed: - Ozempic® was superior to treatment with the SGLT-2 inhibitor canagliflozin (300 mg) in reducing HbA1c and ...
more
05.08.2019 – 13:12
Technische Universität München
Dry feed for superfood producers: study investigates nutritional behavior of insects
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10516 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35635/ High resolution pictures: https://mediatum.ub.tum.de/1516504 NEWS RELEASE International study investigates nutritional behavior of insects Dry feed ...
more
02.07.2019 – 15:27
artgerecht GmbH
Word Weer Mens - Cookbook, Specialist Book, Health Book ... and Much More
more
11.06.2019 – 12:00
APR Applied Pharma Research s.a.
29th EWMA Conference: Latest Clinical Data on Nexodyn® AOS Demonstrating Higher Healing Performance in Chronic Leg Ulcers Presented by Applied Pharma Research
Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa (APR) presented at the recent 29th conference of the European Wound Management Association (EWMA) in Göteborg, the results of a clinical study confirming Nexodyn® AcidOxidizing Solution (AOS) to promote the restart of the healing process in ...
more
02.05.2019 – 14:08
Helmholtz Zentrum München
Pluripotency or differentiation - that is the question
more
30.04.2019 – 14:05
Merck KGaA
Merck to Present New Data on Mavenclad®, Rebif® and the Investigational Therapy Evobrutinib at the AAN Annual Meeting 2019
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. or U.K. based media - 20 abstracts will be presented during the AAN Annual Meeting 2019 to demonstrate Merck's commitment and clinical development program in multiple sclerosis Merck, a leading science and technology company, today announced that data from ...
more
28.03.2019 – 12:44
Selvita
Selvita to Separate Oncology Therapeutics and Contract Research Business Units Into Two Global Companies
Krakow, Poland (ots/PRNewswire) - Two publicly traded companies to offer distinct opportunities for investment and growth Selvita (WSE: SLV), a clinical stage company engaged in the research and development of novel cancer therapies as well as provision of drug discovery and development services, today announced ...
more
19.03.2019 – 09:59
Daiichi Sankyo Europe GmbH
CLEAR Wisdom Demonstrated First-in-class, Oral, Once-daily, ACL Inhibitor Bempedoic Acid Significantly Lowered LDL-Cholesterol and Reduced hsCRP
Munich and Ann Arbor, Michigan (ots/PRNewswire) - - Late-Breaking Presentation of Final Results of Bempedoic Acid Pivotal Phase 3 CLEAR Wisdom at the American College of Cardiology (ACC) 2019 Scientific Sessions - Over 52-Weeks, Bempedoic Acid was Observed to be Safe, Well-Tolerated and Adverse Event Profile was ...
more
06.11.2018 – 09:02
Primary Care Diabetes Europe (PCDE)
Primary Care Diabetes Europe Issues Call to Action Against Clinical Inertia in the Treatment of Type-2 Diabetes
Ekeren, Belgium (ots/PRNewswire) - Research identifies lack of primary care physician adherence to treatment guidelines among the challenges to optimal care for patients with type-2 diabetes Primary Care Diabetes Europe (PCDE) today issued a call to action challenging primary care physicians and other healthcare ...
more
29.10.2018 – 12:12
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Press release: A breakthrough in cardiac metabolic MR imaging
more
25.10.2018 – 13:34
Helmholtz Zentrum München
Two-pronged approach - Novel combined therapy tackles excess fatty tissue
A new combined therapy for obesity and diabetes has been shown to suppress the appetite and at the same time increase energy expenditure. Scientists from the Helmholtz Zentrum München and the Technical University of Munich (TUM), partner institutions of the German Center for Diabetes Research (DZD), have reported their findings in 'Nature Communications'. "Obesity is ...
more
18.10.2018 – 15:29
Technische Universität München
Thomas Hofmann elected as TUM's new President
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/detail/article/35004/ Images: https://mediatum.ub.tum.de/1232766 NEWS RELEASE Thomas Hofmann elected as TUM's new President Experienced university manager and acclaimed scientist takes the helm at Technical University ...
more
11.10.2018 – 12:57
Janssen Pharmaceutica
Janssen to highlight data from broad rheumatology portfolio at the 2018 Annual meeting of the American College of Rheumatology
Beerse, Belgium (ots/PRNewswire) - - One-year results from the Phase 2 study evaluating STELARA® (ustekinumab) in patients with active systemic lupus erythematosus featured in a plenary presentation - 13 presentations from approved and pipeline products provide real-world treatment and disease insights across ...
more
09.10.2018 – 10:15
Helmholtz Zentrum München
Satiety in 3D
Many overweight people lack the feeling of being full. It was long thought that this was due to the disrupted transport of the satiety hormone leptin to the brain. That is not the case, as a group of scientists from Helmholtz Zentrum München has now shown in the 'International Journal of Obesity'. The work was made possible by a new 3D imaging technique that allows tracking the path of the hormone in the brain as shown in the video image enclosed. Leptin is an important ...
more
05.07.2018 – 12:00
Jennewein Biotechnologie GmbH
Jennewein Biotechnologie to build new R&D centre for synthetic organisms and microbiome research in Bonn, Germany
Rheinbreitbach (ots) - Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg, which will be the site of a new R&D centre for microbiome research and designer microorganisms. "The relocation of part of our ...
more
13.06.2011 – 14:32
Astellas Pharma Europe Limited
Interim Data From Phase 2 Trial of AC220 Monotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia With FLT3-ITD Activating Mutations
London (ots/PRNewswire) - Ambit Biosciences Corporation and Astellas Pharma Inc. announced today results from a planned interim analysis in an ongoing Phase 2 study evaluating AC220, a potent and selective FLT3 inhibitor. The study is evaluating AC220 as an oral, once-a-day, monotherapy treatment in acute myeloid ...
more

1